Eric Dilbone, MD
Adult Reconstructive Orthopaedic Surgery · Morrisville, NCNPI 1043717788
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (32.2%), grants and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 85.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $13,317 and has fallen 89.2% since, to $1,432 in 2025.
Across 87 payments — averaging $320.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$24K
- Zimmer Biomet$2K
- Stryker$1K
- Intellijoint Surgical Inc.$154
- Medacta USA, Inc.$118
- Peerless Surgical Inc.$87
- plus $125 from 4 others
What the payments were for
- Grants$8,75031%
- Travel & lodging$5,01918%
- Food & beverage$5,13018%
- Education$8,99232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 36 | $23,701 |
| Zimmer Biomet | 31 | $2,250 |
| Stryker | 12 | $1,456 |
| Intellijoint Surgical Inc. | 1 | $154 |
| Medacta USA, Inc. | 1 | $118 |
| Peerless Surgical Inc. | 2 | $87 |
| Onkos Surgical, Inc. | 1 | $39 |
| Heron Therapeutics, Inc. | 1 | $37 |
| Davol Inc. | 1 | $29 |
| Bioventus LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$6,092
- REAL INTELLIGENCE$4,495
- OR3O Dual Mobility$1,614
- Legion$1,407
- Legion Revision$1,379
- REDAPT$791
- MAKO$782
- Persona$626
- TITAN$529
- ROSA$437
- INSIGNIA$165
- Intellijoint HIP$154
- TRIATHLON$151
- Oxford$148
- GMK SPHERE$118
How this compares
Too few adult reconstructive orthopaedic surgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 39 | $85 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Morrisville
- David PollockBermuda Run$4.8M
- Thorsten SeylerDurham$2.2M
- Adam BrekkeDurham$86K
- John ShieldsWinston Salem$78K
- Andrew SchwartzDurham$75K
- Jason NorcrossHickory$55K
- Walter FruehWilmington$26K
- David CaseyPinehurst$20K
- Charles LongHendersonville$18K
- Bernard KemkerRocky Mount$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.